IAPAM Learning Library

The neurotoxin market is segmenting by duration, offering providers options from 2-3 weeks to 6 months for personalized patient care. January 2026 also brought Level 1 evidence for neck rejuvenation, clinical data on regenerative approaches, and FDA clearances expanding aesthetic devices into medical applications.

Is weight regain inevitable after you stop taking GLP‑1 drugs like Ozempic or Wegovy? This article explains why most people regain, what the “keep it off” group does differently, and how holistic programs like Clean Start Weight Loss® can help you plan for life beyond injections.

Discover 5 hidden GLP-1 side effects linked to malnutrition—from chills to hair loss. Learn warning signs, timelines, and why comprehensive lifestyle support is essential for safe weight loss.

Treating platysma bands with neurotoxins represents a significant opportunity for aesthetic practitioners to differentiate their expertise beyond traditional facial injections. However, mastering this advanced neck rejuvenation technique requires comprehensive training in complex anatomy, risk management, and patient selection to ensure safe, effective outcomes.

October 2025 brought major regulatory and clinical updates shaping aesthetic medicine—from the FDA’s RF microneedling alert to new neurotoxin and device approvals. These developments highlight how evidence-based innovation and patient education are redefining safe, inclusive, and profitable practice growth.